Bragg Financial Advisors, Inc
Source: SEC Form 13F · as of Mar 2026Bragg Financial Advisors, Inc holds 15 biotech & pharma companies tracked by BioSniper, totaling $119.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$119.5M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 88,681 | $21.7M |
| AMGNAMGEN INC | 51,053 | $18.0M |
| ABBVAbbVie Inc. | 74,063 | $16.1M |
| MRKMerck & Co., Inc. | 133,013 | $16.0M |
| LLYELI LILLY & Co | 14,121 | $13.0M |
| ABTABBOTT LABORATORIES | 115,194 | $11.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 33,145 | $9.0M |
| PFEPFIZER INC | 273,539 | $7.7M |
| ZTSZoetis Inc. | 17,573 | $2.1M |
| BMYBRISTOL MYERS SQUIBB CO | 28,885 | $1.8M |
| ELVElevance Health Inc. | 4,503 | $1.3M |
| PMPhilip Morris International Inc | 2,153 | $356K |
| MCKMcKesson Corporation | 306 | $265K |
| CAHCardinal Health Inc. | 1,203 | $254K |
| IDXXIDEXX LABORATORIES INC /DE | 384 | $216K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.